TGen, Barrow Neurological Institute at St. Joseph’s Hospital, and Phoenix Children’s Hospital are collaborating on a new study to identify a biomarker for secondary injuries associated with ruptured brain aneurysms and subarachnoid hemorrhage.
The $4 million, five-year federal grant to the three Phoenix institutions will also attempt to lower medical costs, speed patient recovery and identify patients at risk for injury.
The molecular profile— comprised of RNA, the body’s relay messenger between DNA and protein—could help identify which patients are most at risk for vasospasm after hemorrhagic stroke.
By identifying this RNA molecular marker, a new standard of individualized care could be established, enabling medical teams to respond more rapidly to quickly changing health conditions, and allowing earlier intervention to prevent a secondary injury from occurring.
For more information: